Antimicrobial utilization research and activities in Botswana, the past, present and the future

0Citations
Citations of this article
34Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

A number of activities are ongoing to reduce AMR in Botswana by improving antimicrobial utilization across all sectors. However, there is a need to share experiences. With the objective of sharing these, the second one day symposium was held in the University of Botswana in October 2018 involving both private and public hospitals. In Lenmed Bokamoso hospital, ESKAPE organisms were associated with 50-90% of clinical infections; however, there was no correlation between healthcare associated infections (HAIs) and admission swab positivity with ESKAPE or ESBL isolates. Hang times, the time between a prescription and IV administration, were also discussed. At Nyangabwe Hospital, the prevalence of HAIs was 13.54%, 48.9% were laboratory confirmed of which 8.5% were blood stream infections (BSIs). The prevalence of different bacteria causing neonatal BSIs was also investigated. At Princess Marina Hospital, positive cultures were seen in 22.4% of blood cultures with contaminants comprising the majority. Several activities are ongoing in Botswana across sectors as a result of the findings and will be periodically reported to further improve antibiotic utilization.

Cite

CITATION STYLE

APA

Tiroyakgosi, C., Matome, M., Kgatlwane, J., Anand Paramadhas, B. D., Malone, B., Mpinda-Joseph, P., … Massele, A. (2019). Antimicrobial utilization research and activities in Botswana, the past, present and the future. In Expert Review of Anti-Infective Therapy (Vol. 17, pp. 759–762). Taylor and Francis Ltd. https://doi.org/10.1080/14787210.2019.1668777

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free